📲 Install as app Add Insight Labs to your home screen — daily brief, one tap away.

Add Insight Labs to your home screen

Get the daily brief like an app — one tap, no browser bar, works offline.

  1. Tap the button at the bottom of Safari
  2. Scroll and tap Add to Home Screen
  3. Tap Add in the top right — done

Works on iPhone & iPad. The icon will appear like any app.

Edition #202

The Insight Labs Daily.

Sat · Aug 01 · 2026 ~6 min read
★ Lead Story
Reported Jul 31 · 2 min read

Adani's cooking-oil giant is making its new money off the label, not the oil

AWL Agri Business, the Adani-Wilmar company behind Fortune oil, approved its June-quarter results on July 30. Revenue rose 18% to 20,048 crore rupees and net profit climbed 48% to 351 crore.

The number that matters sits one line lower. The food and FMCG arm crossed 100 crore rupees of quarterly operating profit for the first time, at 104 crore, on revenue up 22%. The edible-oil business, the reason the company exists, grew revenue 13% while its volumes stayed flat.

So the growth this quarter came from the packets, not the pouches of oil. Rising oil prices lifted the top line, but the profit was made where the brand does the selling.

A staples company earns thin margins on a commodity and reaches almost every kitchen in the country. The question it keeps testing is whether that reach can be resold at food-brand margins.

The wider FMCG segment grew volume 17% even as edible oil stayed flat, which tells you where the household is trading up. Foods, rice, pulses and ready mixes carry pricing power that a litre of oil never will.

The risk is that the same distribution advantage is now being chased by every large grocer and every quick-commerce shelf. Owning the truck to the store no longer guarantees owning the basket inside it.

Watch whether the food arm's operating profit holds above 100 crore for a second quarter. One crossing is a milestone; two in a row would make the pivot look structural rather than seasonal.

Today's Top 5

5 stories
Sun Pharma · Reported Jul 31

Sun Pharma's profit grew where its chemistry is newest

On July 31 Sun Pharma, India's largest drugmaker, reported June-quarter net profit up 27% to 2,895 crore rupees, on revenue up 10% to 15,300 crore.

The growth came from two places: the branded business at home, and the specialty medicines it now sells in the United States. The plain generics that built the company stayed under price pressure.

That is the slow migration in Indian pharma. The margin is moving from copying old molecules cheaply to selling a few new ones dearly.

Specialty products carry patents, marketing muscle and prices that generics cannot hold. Each one that ramps changes the shape of the profit pool more than another generic launch would.

The caveat is concentration. A specialty portfolio leans on a handful of products, so a single approval delay or a rival launch moves the whole quarter.

Titan · Q1 update

Titan's jewellery counter is doing the work of a whole company

Titan's June-quarter update showed its consumer businesses up 41%, led by jewellery up 39%. Watches and eyecare each grew 23%, and the international arm, mostly jewellery, rose 128%.

Stable gold prices brought buyers back after a jittery run, and buyer numbers grew in double digits. The bigger lift came from ticket sizes, which rose faster than footfall.

So the quarter was built less on more people walking in and more on each of them spending up.

CaratLane grew 39% and the store network reached about 3,680 outlets, which is how Titan keeps converting a wedding-led habit into a year-round one.

The watch to keep is whether the jump survives a gold price that moves the other way. Premiumisation is durable; a stable metal price is not guaranteed.

Core Sector · Data Jul 31

India's core industries had their best month since winter

Government data on July 31 put core-sector output up 5% in June, the fastest in five months. It was the first reading under a new 2022-23 base year, which added iron ore as a ninth tracked industry.

The lift came from what goes into buildings. Cement and power rose about 10% each and iron ore jumped 44%, while crude oil, natural gas, refinery products and fertiliser all fell.

So the recovery is being carried by construction, not energy, and the split is worth watching.

For the April-June quarter, cumulative core growth was 3.6%, more than triple the 1% of a year earlier, which points to a firmer base for the rest of the year.

Construction-led strength usually shows up later in cement bags, steel and eventually the durable goods that fill a new home. The energy softness is the reminder that the recovery is not yet broad.

Factories · Data this week

The factory floor sped up while the service desk slowed down

India's HSBC manufacturing PMI rose to 59.1 in July, a 16-month high, even as the services reading fell to 53.1, its weakest in more than four years. The two pulled the combined index down to 54.3.

Anything above 50 still means growth, so neither engine has stalled. What changed is the direction: goods are accelerating, services are cooling.

Part of the factory strength was defensive. Manufacturers built extra stock as unrest in West Asia made them wary of supply gaps.

A services slowdown matters because services are the larger share of output and the bigger employer of white-collar India. A one-month dip is noise; a trend would be a demand signal.

Precautionary stock-building flatters a factory reading now and can drag it later, once the buffer is full and new orders have to carry the index alone.

Startups · Last week

Startup money is pooling around the companies closest to a listing

Indian startups raised about 209 million dollars last week, led by Zetwerk's 52 million dollar pre-IPO round. The pattern through July was fewer cheques, written larger, for mature names.

AI, electric mobility and fintech took the biggest sums, while the earliest-stage founders saw the thinnest slice.

So investors are paying for proximity to an exit rather than distance from one.

The month's largest disclosed round was Emergent's 130 million dollars, and a crowded IPO pipeline is pulling late-stage capital toward companies that can list within a year.

The quiet cost is the seed stage. When money clusters at the top, the next generation of companies gets funded more slowly, and the effect shows up two or three years out.

⚡ 30-Second Scan

Government finances: India's April-June fiscal deficit reached 18.2% of the full-year target as capital spending rose to 3.4 lakh crore rupees, a faster start than the same quarter last year (Business Standard, Jul 31).
Edtech IPO: Klassroom fixed a 151 to 159 rupee band for its SME IPO, which opened July 31 and closes August 4 (YourStory, Jul 31).
The skies: India flew 864 lakh domestic passengers in the first half of 2026, up 1.4%, with IndiGo at a record 66.3% share (Ministry of Civil Aviation).

Sourced from public reporting; analysis by The Insight Labs.

Sources: AWL Agri Business filings, Business Standard, Investing.com, Sun Pharma results, Business Today, Titan Q1 FY27 update, Indian Retailer, Goodreturns, Index of Core Industries, Forbes India, The Tribune, HSBC, S&P Global PMI, Republic World, PMI.SPGlobal, Startup funding roundup, Inc42.

Want the Tuesday deep-dive?

The Insight Labs newsletter · every Tuesday · one full FMCG case-study from inside the P&L. Free.

Subscribe →
Today's edition · ~8 min read